Dexoligo Therapuetics
Manufacturing · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
154 Menakhem Begin Rd, Tel Aviv, IsraelWebsite
www.dexoligo.comRevenue
<$5 MillionIndustry
About Dexoligo Therapuetics
Dexoligo Therapuetics Org Chart
Is Dexoligo Therapuetics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Dexoligo Therapuetics has recently received funding, and reach out quickly before it becomes old news!
Click to see if Dexoligo Therapuetics had a recent Job posting/layoffs
Earning: See what the market has to say on Dexoligo Therapuetics recently announced quarterly report
Check out if Dexoligo Therapuetics is spiking on competitors!
Funding: Get notified immidiatlly once Dexoligo Therapuetics has new funding data
Dexoligo Therapuetics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Dexoligo Therapuetics
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Dexoligo Therapuetics launches new products
Recommended Actions
Find VP level buyers at Dexoligo Therapuetics
Find 2 more new buyers
Company Profile Activity
Activity Insights
Dexoligo Therapuetics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Dexoligo Therapuetics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Dexoligo Therapuetics.
Dexoligo Therapuetics Tech Stack
A closer look at the technologies used by Dexoligo Therapuetics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Dexoligo Therapuetics
Dexoligo Therapeutics, a division of Dexcel Pharma, specializes in advancing RNA oligonucleotide therapies aimed at addressing critical clinical needs and enhancing patient lives. The company is driven by a team of dedicated scientists focused on developing innovative oligonucleotide drugs to tackle unmet medical challenges. With a commitment to cr... Read More